Disc Medicine, Inc.
NASDAQ:IRONBiotechnology
Healthcare
$76.11 -0.03%
-$0.02 today
- Market cap
- $2.92B
- Beta
- 2.10
- P/E (TTM)
- -11.2
- EPS (TTM)
- -$6.28
52W Low $40.00High $99.50
Volume 0.65M
Average 0.47M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$180.39M
FY 2025 · Annual
Investing Cash Flow
-$394.30M
FY 2025 · Annual
Financing Cash Flow
$473.41M
FY 2025 · Annual
+116.8% YoYCash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (35.97M) | (46.83M) | (76.43M) | (109.36M) | (212.18M) |
| Depreciation & Amortization | 32K | 89K | 100K | 156K | 281K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 507K | 2.09M | 5.53M | 16.82M | 34.34M |
| Change in Working Capital | 1.29M | 2.13M | (2.95M) | 3.23M | 3.53M |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 1.32M | 526K | (3.74M) | (4.68M) | 1.07M |
| Other Working Capital | (29K) | 1.6M | 788K | 7.91M | 2.46M |
| Other Non-Cash Items | 6.61M | 272K | 290K | (4.77M) | (6.36M) |
| Operating Cash Flow | (27.53M) | (42.25M) | (73.46M) | (93.93M) | (180.39M) |
| Capital Expenditures | (68K) | (151K) | (89K) | (505K) | (933K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | (386.63M) | (849.59M) |
| Sales of Investments | 0 | 0 | 0 | 94.8M | 456.22M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (68K) | (151K) | (89K) | (292.33M) | (394.3M) |
| Debt Repayment | (4.58M) | 0 | 0 | 28.99M | 0 |
| Common Stock Issued | 68K | 53.5M | 199.08M | 187.3M | 472.83M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 4.58M | 95.48M | 40.3M | 2.02M | 578K |
| Financing Cash Flow | 89.93M | 148.98M | 239.38M | 218.31M | 473.41M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 62.33M | 106.58M | 165.83M | (167.94M) | (101.29M) |
| Free Cash Flow | (27.6M) | (42.4M) | (73.55M) | (94.43M) | (181.33M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$212.2M
+ D&A$281.0K
+ Stock-Based Comp$34.3M
+ Deferred Tax$0
+ Working Capital$3.5M
- Other Non-Cash-$6.4M
= Operating Cash Flow-$180.4M
- Capex-$933.0K
= Free Cash Flow-$181.3M
Analysis
FY2025 free cash flow is -$181.3M. FCF conversion is 85.5% of net income. Operating cash flow was -$180.4M, with capex of -$933.0K. The largest bridge item is Stock-Based Comp at $34.3M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 12, 2026 | |
| 10-Q | Quarterly report | Nov 5, 2026 | |
| 8-K | Current report | Nov 5, 2026 | |
| 424B5 | 424B5 filing | Nov 5, 2026 | |
| SC 13D/A | SC 13D/A filing | Oct 26, 2026 |
Does IRON generate free cash flow?
Disc Medicine, Inc. (IRON) generated -$181.33M of free cash flow in fiscal 2025.
How much operating cash flow does IRON produce?
Operating cash flow was -$180.39M, before capital expenditures of $933,000.00.
Continue the stock analysis
Jump to another research area for this company.